Cite
Manzotti G, Mariani SA, Corradini F, et al. Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells. Blood Cancer J. 2012;2(5):e71doi: 10.1038/bcj.2012.16.
Manzotti, G., Mariani, S. A., Corradini, F., Bussolari, R., Cesi, V., Vergalli, J., Ferrari-Amorotti, G., Fragliasso, V., Soliera, A. R., Cattelani, S., Raschellà, G., Holyoake, T. L., & Calabretta, B. (2012). Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells. Blood cancer journal, 2(5), e71. https://doi.org/10.1038/bcj.2012.16
Manzotti, G, et al. "Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells." Blood cancer journal vol. 2,5 (2012): e71. doi: https://doi.org/10.1038/bcj.2012.16
Manzotti G, Mariani SA, Corradini F, Bussolari R, Cesi V, Vergalli J, Ferrari-Amorotti G, Fragliasso V, Soliera AR, Cattelani S, Raschellà G, Holyoake TL, Calabretta B. Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells. Blood Cancer J. 2012 May;2(5):e71. doi: 10.1038/bcj.2012.16. Epub 2012 May 11. PMID: 22829973; PMCID: PMC3366069.
Copy
Download .nbib